Literature DB >> 16440437

Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy.

Tae-Hun Kim1, Jong-Eun Joo.   

Abstract

A 39-year-old male patient complaining of bilateral hand joint arthralgia was evaluated and found to have chronic hepatitis C and systemic sarcoidosis involving lung, skin, liver, and spleen. Hepatic and cutaneous sarcoidoses were confirmed by the presence of numerous noncaseating granulomas on histological examination. Pulmonary and splenic involvements were diagnosed by imaging studies. Fifteen months later, the sarcoidotic lesions in lung, liver, and spleen were resolved by radiological studies and a liver biopsy showed no granuloma but moderate to severe inflammatory activity. systemic sarcoidosis is a rare comorbidity of chronic hepatitis C which may spontaneously resolve.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440437      PMCID: PMC4077494          DOI: 10.3748/wjg.v12.i1.150

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients.

Authors:  M Bilir; A Mert; R Ozaras; H Yanardag; T Karayel; H Senturk; V Tahan; G Ozbay; A Sonsuz
Journal:  J Clin Gastroenterol       Date:  2000-12       Impact factor: 3.062

Review 2.  Radiology of the spleen.

Authors:  F Robertson; P Leander; O Ekberg
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 3.  Reactivation of sarcoidosis during interferon therapy.

Authors:  Shilun D Li; Sherri Yong; Dasarathy Srinivas; David H Van Thiel
Journal:  J Gastroenterol       Date:  2002-01       Impact factor: 7.527

4.  Nodular hepatic and splenic sarcoidosis in a patient with normal chest radiograph.

Authors:  Loukas Thanos; Alexandra Zormpala; Elias Brountzos; Alexandra Nikita; Dimitrios Kelekis
Journal:  Eur J Radiol       Date:  2002-01       Impact factor: 3.528

Review 5.  Management issues in chronic viral hepatitis: hepatitis C.

Authors:  William Sievert
Journal:  J Gastroenterol Hepatol       Date:  2002-04       Impact factor: 4.029

Review 6.  Sarcoidosis 2001.

Authors:  D G James
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

7.  Sarcoidosis-associated hepatitis C virus infection.

Authors:  F Bonnet; P Morlat; J Dubuc; S De Witte; M Bonarek; N Bernard; D Lacoste; J Beylot
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

8.  [Sarcoidosis and comorbidity: retrospective study of 32 cases].

Authors:  F Bonnet; J Dubuc; P Morlat; X Delbrel; M S Doutre; S de Witte; N Bernard; D Lacoste; M Longy-Boursier; J Beylot
Journal:  Rev Med Interne       Date:  2001-07       Impact factor: 0.728

Review 9.  Extrapulmonary sarcoidosis primarily diagnosed in the liver.

Authors:  S Mueller; M W Boehme; W J Hofmann; W Stremmel
Journal:  Scand J Gastroenterol       Date:  2000-09       Impact factor: 2.423

10.  Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.

Authors:  R Pérez-Alvarez; R Pérez-López; J L S Lombraña; M Rodríguez; L Rodrigo
Journal:  J Viral Hepat       Date:  2002-01       Impact factor: 3.728

View more
  3 in total

1.  Relationship between the pathogenesis of sarcoidosis and hepatitis C.

Authors:  Sevtap Sipahi Demirkok
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

2.  Delayed enhanced hepatosplenic sarcoid nodules on computed tomography in an interferon-naïve hepatitis C patient: a case report and review of the literature.

Authors:  Takuhiro Ugajin; Hiroyuki Miyatani; Katsuhiko Matsuura; Shinya Ushimaru; Kiyoka Omoto; Mitsuhiro Nokubi; Tomohisa Ohkohchi; Yukio Yoshida
Journal:  Clin J Gastroenterol       Date:  2012-10-13

3.  Therapeutic Dilemma of Sarcoidosis and Treatment-naïve Hepatitis C Manifesting as Tattoo Reactions.

Authors:  Naoto Ishimaru; Jun Ohnishi; Hiroyuki Seto; Yohei Kanzawa; Nobuya Sano; Saori Kinami
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.